V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10009113 | 10004448 | 0 | null | Palliative (P) | 2017-07-16 | 2017-07-16 | Trial Unspecified | N | N | 10443855 | TRIAL |
| 10009114 | 10004456 | 1.83 | 82 | null | 2017-12-15 | 2017-12-16 | Azacitidine | N | N | 10445140 | AZACITIDINE |
| 10009115 | 10004468 | 1.58 | 63 | Disease modification (D) | 2018-06-20 | 2018-06-22 | Bendamustine+Rituximab(Sub Courses) | 2 | N | 10446319 | BENDAMUSTINE + RITUXIMAB |
| 10009116 | 10004472 | null | 99 | Palliative (P) | 2016-06-27 | 2017-01-29 | Abiraterone | N | null | 10448196 | GEMCARBO |
| 10009117 | 10004490 | null | 67.8 | Palliative (P) | 2018-07-29 | 2018-07-29 | Carboplatin AUC 6 - 10 | 02 | N | 10449839 | CARBOPLATIN |
| 10009118 | 10004497 | 1.75 | 69.8 | Adjuvant (A) | 2016-06-03 | 2016-06-03 | CARBOPLATIN | 2 | N | 10450677 | PEMETREXED |
| 10009119 | 10004499 | 1.75 | 82.2 | Palliative (P) | 2017-01-11 | 2017-01-17 | Gemcitabine weekly | 02 | N | 10450803 | PEMETREXED |
| 10009120 | 10004509 | 1.64 | 79.5 | Disease modification (D) | 2015-05-11 | 2015-05-11 | Temozolomide 200mg/m2 | 1 | N | 10451497 | TEMOZOLOMIDE |
| 10009121 | 10004514 | 1.68 | 100.6 | Palliative (P) | 2019-08-26 | 2019-08-29 | CYCLOPHOSPHAMIDE + THALIDOMIDE | N | N | 10451872 | CARBOPLATIN |
| 10009122 | 10004524 | 1.71 | null | null | 2017-01-09 | 2017-04-15 | CARBOPLATIN | N | null | 10453802 | LENALIDOMIDE |
| 10009123 | 10004536 | 1.77 | 64.2 | Palliative (P) | 2017-04-12 | 2017-04-16 | Azacitidine | 02 | Y | 10454558 | AZACITIDINE |
| 10009124 | 10007322 | 1.55 | 100 | Palliative (P) | 2018-04-21 | 2018-08-18 | BENDAMUSTINE + RITUXIMAB | 2 | N | 10455095 | BENDAMUSTINE + RITUXIMAB |
| 10009125 | 10004564 | 1.88 | null | Palliative (P) | 2019-01-02 | 2019-03-26 | GemCarbo Days 1+8 | 2 | N | 10457575 | NOT MATCHED |
| 10009126 | 10004565 | 1.49 | 106.5 | Palliative (P) | 2017-04-23 | 2017-04-23 | Bevacizumab | 2 | N | 10457624 | GEMCITABINE |
| 10009127 | 10004586 | null | 81 | Disease modification (D) | 2017-03-24 | 2017-03-26 | Trial Unspecified | N | N | 10458916 | TRIAL |
| 10009128 | 10008510 | null | 66 | Palliative (P) | 2016-12-08 | 2017-12-09 | Temozolomide 150mg/m2 | N | N | 10460159 | TEMOZOLOMIDE |
| 10009129 | 10004609 | 1.61 | 60.1 | Palliative (P) | 2016-10-04 | 2016-10-06 | Capecitabine | 02 | N | 10461240 | CAPECITABINE |
| 10009130 | 10004614 | null | 107.7 | Palliative (P) | 2018-12-04 | 2019-03-20 | BENDAMUSTINE + RITUXIMAB | 02 | N | 10461654 | BENDAMUSTINE + RITUXIMAB |
| 10009131 | 10004650 | 1.8 | 97.8 | Palliative (P) | 2014-12-17 | 2014-12-17 | CARBOPLATIN + PACLITAXEL | 02 | N | 10465732 | CARBOPLATIN + PACLITAXEL |
| 10009132 | 10004663 | 1.76 | 66.4 | Curative (C) | 2012-03-26 | 2014-10-05 | Capecitabine | null | null | 10467268 | CAPECITABINE |
| 10009133 | 10004696 | 1.63 | 53.7 | Curative (C) | 2019-01-28 | 2019-03-11 | BCG Intravesical | 2 | N | 10470305 | LENALIDOMIDE |
| 10009134 | 10004709 | 1.8 | 53.7 | Palliative (P) | 2019-02-06 | 2019-03-25 | CARBOPLATIN + ETOPOSIDE | 2 | null | 10472325 | CARBOPLATIN + ETOPOSIDE |
| 10009135 | 10007393 | null | 80.2 | Palliative (P) | 2015-08-08 | 2015-11-02 | LENALIDOMIDE | N | N | 10476222 | GEMCARBO |
| 10009136 | 10004727 | 1.67 | 71.1 | Curative (C) | 2017-03-29 | 2017-06-22 | Fluorouricil + Folonic Acid (MdG) | 2 | N | 10477547 | CTD |
| 10009137 | 10007403 | null | 98.3 | Disease modification (D) | 2017-05-09 | 2017-09-13 | Pemetrexed | N | N | 10480034 | NOT MATCHED |
| 10009138 | 10004769 | 1.63 | 70.3 | Palliative (P) | 2017-12-23 | 2018-01-28 | Pemetrexed | 2 | null | 10481342 | CARBOPLATIN + VINORELBINE |
| 10009139 | 10004772 | 1.82 | 69.55 | Palliative (P) | 2018-10-22 | 2018-10-26 | NIVOLUMAB | N | N | 10481483 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 10009140 | 10007416 | 1.74 | 80.3 | Palliative (P) | 2017-02-13 | 2017-02-21 | Docetaxel + Nintedanib | 02 | N | 10482327 | CAV |
| 10009141 | 10004816 | 1.7 | 0 | Palliative (P) | 2018-03-16 | 2018-05-27 | CETUXIMAB + IRINOTECAN + MDG | N | N | 10485023 | MITOMYCIN |
| 10009142 | 10004853 | 1.68 | 95.6 | Palliative (P) | 2019-01-26 | 2019-02-02 | Cetuximab + FLUOROURACIL + OXALIPLATIN | 2 | N | 10487753 | PROCARBAZINE |
| 10009143 | 10004859 | 1.75 | 78.4 | Palliative (P) | 2017-10-18 | 2018-12-20 | FLAG + Idarubicin | N | null | 10487958 | CETUXIMAB + IRINOTECAN + MDG |
| 10009144 | 10004865 | 1.53 | 58 | Disease modification (D) | 2018-10-13 | 2018-10-14 | Carboplatin + Liposomal Doxorubicin | 2 | N | 10488696 | DOCETAXEL + NINTEDANIB |
| 10009145 | 10004919 | 1.83 | 107 | Palliative (P) | 2016-12-30 | 2017-06-08 | Cetuximab + Radiotherapy Maint | 2 | N | 10495054 | MPV |
| 10009146 | 10004924 | 1.63 | 54.1 | Palliative (P) | 2014-11-06 | 2014-11-07 | Doce + Pertuzumab + Trastuz IV Maint | 2 | N | 10496656 | LANREOTIDE |
| 10009147 | 10004927 | 1.57 | 49.7 | Palliative (P) | 2017-08-20 | 2018-03-14 | FEC | N | N | 10496956 | CAPECITABINE + GEMCITABINE |
| 10009148 | 10004942 | 1.74 | 90.6 | Palliative (P) | 2018-04-17 | 2018-05-15 | GDP | N | N | 10502066 | CAPECITABINE + CARBOPLATIN |
| 10009149 | 10004953 | 1.72 | 73 | Palliative (P) | 2019-03-09 | 2019-03-25 | VEPEMB | 2 | N | 10502964 | IMATINIB |
| 10009150 | 10004963 | 1.7 | 53.9 | Palliative (P) | 2017-11-12 | 2017-12-03 | EOX | N | N | 10504251 | DABRAFENIB |
| 10009151 | 10004968 | 1.59 | 90.3 | Palliative (P) | 2018-01-30 | 2018-02-21 | Chlorambucil | N | N | 10504393 | FCR |
| 10009152 | 10004975 | 1.71 | 0 | Curative (C) | 2016-02-10 | 2017-05-01 | NIVOLUMAB | 02 | N | 10505533 | LOMUSTINE |
| 10009153 | 10004995 | 1.72 | 78.4 | Curative (C) | 2018-05-23 | 2018-08-04 | CHLVPP | N | N | 10507380 | CISPLATIN + PEMETREXED |
| 10009154 | 10007514 | 1.75 | 91.4 | Palliative (P) | 2018-06-18 | 2018-06-19 | CABOZANTINIB | 2 | N | 10508636 | ARSENIC TRIOXIDE + TRETINOIN |
| 10009155 | 10005005 | 1.7 | 90.9 | Palliative (P) | 2018-02-07 | 2018-02-10 | Carboplatin + Liposomal Doxorubicin | 02 | N | 10508761 | EC |
| 10009156 | 10005012 | null | 99 | Palliative (P) | 2015-05-21 | 2015-07-12 | DA 3+8 | 02 | N | 10509197 | ENRICH TRIAL |
| 10009157 | 10005015 | 1.74 | 79.5 | Curative (C) | 2016-11-09 | 2016-11-12 | Mitomycin Intravesical | 02 | N | 10509678 | OXALIPLATIN + MDG + PANITUMUMAB |
| 10009158 | 10007521 | null | 80 | Adjuvant (A) | 2016-03-01 | 2016-03-02 | Bortezomib +/- Dexamethasone | 1 | N | 10509722 | DOCETAXEL + NINTEDANIB |
| 10009159 | 10005026 | 1.7 | 65.2 | Palliative (P) | 2015-12-27 | 2016-02-24 | Capecitabine + Carboplatin + RT | 02 | N | 10510063 | RUXOLITINIB |
| 10009160 | 10005036 | 1.69 | 73.1 | Palliative (P) | 2018-03-09 | 2018-03-14 | RUXOLITINIB | 02 | N | 10511670 | EOX |
| 10009161 | 10005041 | 1.71 | 69.9 | Palliative (P) | 2015-01-08 | 2015-02-05 | Cisplatin + Gemcitabine (D 1 & 8) | 02 | N | 10512345 | CETUXIMAB + IRINOTECAN + MDG |
| 10009162 | 10005054 | 1.66 | 65.7 | Curative (C) | 2018-08-06 | 2018-08-12 | Vincristine (weekly) | N | N | 10514513 | CAPECITABINE + CISPLATIN + EPIRUBICIN |